 |
 |
Important Notice: The Forum does not endorse any medical
product or therapy. ALL medications and supplements
should be taken ONLY under the supervision of a physician,
due to the possibility of side-effects, drug interactions,
etc.
|
Animal Model:
|
Neuregulin 1 Hypomorph (Transmembrane Domain)
|
|
Preparation Type:
|
Genetic Preparations
|
|
DA-related behavior:
|
Hyperactive in open field test
|
|
Gating:
|
Disrupted PPI
|
|
Cognitive behavior:
|
No impairment in spatial learning or working memory but
diminished social recognition memory
|
|
Social behavior:
|
Increase in dominance related and aggressive behavior
depending on environment
|
|
Molecular/morphological signature:
|
Reduced NMDA receptor activity; increased serotonin 2A
receptors and serotonin transporters in CNS
|
|
Response to APD:
|
Open field behavior reversed by clozapine but not PPI
|
|
Citations:
|
Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir
S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S,
Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H,
Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B,
Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D,
Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J,
Johannesson G, Andresson T, Gudbjartsson D, Manolescu A,
Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H,
Stefansson K. Neuregulin 1 and susceptibility to
schizophrenia. Am J Hum Genet . 2002 Oct 1 ; 71(4):877-92.
Abstract
|
|
|
 |
|
 |